Basic Information
Aviron Ltd is engaged in the research and development of specific antiviral agents for chronic hepatitis C virus (HCV) infections. The company has established strategic alliances with CHEMRAR High Tech Center, the Institute of Chemical Diversity, and DRUGS TECHNOLOGY, Ltd. Aviron Ltd was founded in 2010 and is headquartered in Moscow, Russian Federation.